Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 2002

Haiman Christopher A, Hankinson Susan E, Spiegelman Donna, Brown Myles, Hunter David J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aromatase
Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Polymorphism, Genetic

Share to Regression Analysis

Share to Risk Factors

Source

Identifiers

PMID: 11867511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.PMID 11867511Read ↗

Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.Semantic proximity Read ↗

CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study.Semantic proximity Read ↗

Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.Semantic proximity Read ↗

Polymorphic variation in CYP19 and the risk of breast cancer.Semantic proximity Read ↗

Genetic variants in hormone-related genes and risk of breast cancer.Semantic proximity Read ↗

No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer.Semantic proximity Read ↗

No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women.Semantic proximity Read ↗

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.Semantic proximity Read ↗

No association between BRCA2 N372H and breast cancer risk.Semantic proximity Read ↗

Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.Semantic proximity Read ↗

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.Semantic proximity Read ↗

A systematic review of genetic polymorphisms and breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.